Global Interventional Cardiology Market, By Device Type (Conventional Device, Advanced Device), End User (Hospitals, Clinics, Cardiac Catheterization Laboratories, Ambulatory Surgical Centres, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Interventional Cardiology Market
The interventional cardiology market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 27,339.73 million by 2028 and is expected grow at a CAGR of 7.99% in the above mentioned forecast period.
Interventional cardiology is a branch of cardiology which deals exclusively with the catheter based treatment of structural heart diseases. Most of the interventional cardiology procedures are considered to be minimally invasive as these do not engross the use of multiple instruments to enter the body or large incisions.
The rapid increase in chronic diseases such as diabetes and cardiac diseases is amongst the significant factors expected to fuel the growth and demand of interventional cardiology market. In addition, the high incidences of cardiac diseases accompanied by the increase in healthcare expenditure in the medical device are also anticipated to push the growth in the global interventional cardiology market over the forecast period of 2021 to 2028. Likewise, the rapid increase in geriatric population, rapid change in lifestyle and the favorable reimbursements for interventional cardiology procedures are also projected to lift the growth of the market. Furthermore, the rise in tobacco consumption and increase in the incidence of obesity is also expected to act as significant factors which will flourish the growth of the interventional cardiology market.
The rise in patient awareness for advanced medical devices and increase in the occurrence of lifestyle disorders are expected to offer significant growth opportunities for the interventional cardiology market in the forecast period of 2021 to 2028.
However, the availability of alternative treatments and low affordability and inaccessibility of cardiac surgeries in developing countries are estimated to limit the growth of the interventional cardiology market, whereas, the strict regulatory requirements delaying the approval of cardiac devices can challenge the growth of the interventional cardiology market.
This interventional cardiology market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the interventional cardiology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Interventional Cardiology Market Scope and Market Size
The interventional cardiology market is segmented on the basis of device type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- The device type segment of the interventional cardiology market is segmented into conventional device and advanced device. Conventional device has further been segmented into cardiac catheters, PTCA balloons, coronary stents, cardiac valves and others. Advanced device has further been segmented into intravascular ultrasound (IVUS), fractional flow reserve (FFR) and optical coherence tomography (OCT).
- The interventional cardiology market has also been segmented based on the end user into hospitals, clinics, cardiac catheterization laboratories, ambulatory surgical centers and others.
Interventional Cardiology Market Country Level Analysis
The interventional cardiology market is analyzed and market size insights and trends are provided by country, device type and end user as referenced above.
The countries covered in the interventional cardiology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the interventional cardiology market owing to strong presence of technologically advanced healthcare infrastructure and rise in preference for minimally invasive procedures for correction of heart defects. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the increase in the cases of chronic diseases and rise in aging populations.
The country section of the interventional cardiology market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The interventional cardiology market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for interventional cardiology market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the interventional cardiology market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Interventional Cardiology Market Share Analysis
The interventional cardiology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to interventional cardiology market.
The major players covered in the interventional cardiology market report are ABIOMED, Inc., ACIST Medical Systems, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, BD, Cook, Cardinal Health, Edwards Lifesciences Corporation, Ivascular, S.L.U., Johnson & Johnson Services, Inc., Medtronic, Merit Medical Systems, Koninklijke Philips N.V., Abbott, Terumo Corporation, Rontis Corporation, W. L. Gore & Associates, Inc., Biosensors International Group, Ltd., and GENERAL ELECTRIC COMPANY among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.